There is no doubt that modern lifestyle changes have contributed to the problems of overweight and obesity among adults and children. Some school health and physical education programs are tackling the challenge of integrating healthier eating and regular exercise into the lives of students. But what about the social challenges that face children who are overweight? And how do media messages reinforce the bias they already experience among many of their peers? In these lessons, students will evaluate both their own biases related to size differences and the ways in which media shape those biases.

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"Individuals with metabolic syndrome have a 2-fold increased risk of cardiovascular disease, but few strategies provide adequate cardiovascular risk reduction for this group. One option to lower this risk is to reduce atherogenic lipids, particularly low-density lipoprotein cholesterol. Statins are a recommended first-line therapy for this purpose, but this approach doesn’t always provide sufficient LDL-C lowering to optimally reduce cardiovascular risk. Now, researchers have shown that alirocumab, a proprotein converstase subtilisin/kexin type 9 inhibitor, or PCSK9 inhibitor, approved for LDL-C reduction, may address this need. Pooled clinical trial data from ten phase 3 clinical trials from the ODYSSEY clinical development program showed alirocumab significantly lowered LDL-C in individuals both with and without metabolic syndrome..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"New findings from the ACTIONI-O study suggest that when it comes to tackling weight loss, people with obesity and healthcare professionals don’t always see eye to eye. Reported misconceptions about the factors contributing to obesity and about patient attitudes suggest much room for improving communication and education. In what’s considered the largest study of its type, researchers surveyed more than 14500 people with obesity and more than 2700 healthcare professionals treating patients with obesity in 11 countries. Surveys designed foreach group asked about perceived attitudes, behaviors, and barriers to effective obesity care. For example, patients were asked whether they consider their weight loss completely their responsibility. While clinicians were asked, among other things, to rank criteria they consider in determining whether to spark a discussion with a patient about obesity, such as patient weight, BMI, or mental state..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

This presentation focus on the question: can we cure diabetes? By interviewing different experts we will estimate how possible it is that we will find a cure for diabetes in the future. One of the main arguments is that we already have a cure, which is eating right and exercise, but the big question is whether people are willing to take this cure?

Narrator: Richard Steed.

Many people exercise and take medicine in order to delay or treat type 2 diabetes. However in most cases these interventions in one’s lifestyle fails and the person regain weight and retain their increasing blood glucose levels. Controlling one’s appetite seems to be the key, which is one of the aspects we’ll discuss in this presentation. Furthermore we’ll discuss how gastric bypass surgery helps people with diabetes type 2 controlling their appetite and make their diabetes disappear. Finally we’ll discuss how hormones such as GLP-1 can help diabetics’ control their appetite, and lose weight.

Narrator: Richard Steed.

This presentation address how being overweight and obese is considered one of the strongest predictors, regarding the development of type 2 diabetes. Almost 85 % of people living with diabetes type 2, are either overweight or obese. This is an important aspect, because globally we have a lot of overweight people, in fact in 2014, one in three adults was overweight and one in eight was obese. But why do the numbers keep growing and what’s causing this epidemic growth of obesity?

Narrator: Richard Steed.

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"Looking at these two figures, does one of the solid black circles appear larger than the other? What about these apples? If the apple or the circle on the right looks bigger, your eyes have been fooled by an optical illusion. One that may help fight obesity. Inspired by these illusions, researchers have recently developed a portion-control plate as a means to promote smaller meal sizes. A new study published in the journal, BMC Obesity, evaluates the success of this plate. The World Heath Organization has officially declared obesity to be a global epidemic, with 38% of women and nearly as many men affected world-wide. An important reason for this is an increase in energy intake without the corresponding energy expenditure, and large portion sizes have been implicated as a key player in creating this imbalance. Unfortunately, many people find it a difficult task to learn healthy portion sizes and consistently consume the proper amount of food for every meal..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"Obesity is a prevalent problem worldwide with major health effects. In addition to overall effects, obesity can cause a wide array of gynecological and obstetric complications in women. Because shifts in the vaginal microbiota (VMB) can also be a risk factor for adverse reproductive and health outcomes, researchers examined the relationship between the VMB and obesity. Using sequencing to assess the microbiota in 67 obese women, 42 non-obese women, and 27 women who underwent bariatric surgery, they found a lower prevalence of Lactobacillus and higher prevalence of high-diversity species in the VMB of obese subjects. Local vaginal levels of many inflammatory cytokines were also elevated in obese women, but only IL-1β and IL-8 levels were correlated with VMB diversity. The VMB did not change significantly within 6 months of bariatric surgery, but many womens’ BMIs also remained within the obese range during that time..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"Losing weight through lifestyle interventions alone can be challenging. Unfortunately, the options for effective drug treatment are limited. And those that are available require frequent, daily dosing. Now, a new treatment option tested among patients with diabetes could be a solution for those with obesity but not diabetes. Shown to significantly reduce body weight vs. placebo, efpeglenatide is one of the latest of an entire class of diabetes-targeted drugs observed to have beneficial effects beyond glycemic control. Efpeglenatide is a long-lasting glucagon-like peptide-1 receptor agonist, or GLP-1 RA. The drug is currently being developed to improve glycemic control in patients with type 2 diabetes as a once-weekly subcutaneous administration. But like other GLP-1 RAs, efpeglenatide also helps patients lose weight..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

Psychology is designed to meet scope and sequence requirements for the single-semester introduction to psychology course. The book offers a comprehensive treatment of core concepts, grounded in both classic studies and current and emerging research. The text also includes coverage of the DSM-5 in examinations of psychological disorders. Psychology incorporates discussions that reflect the diversity within the discipline, as well as the diversity of cultures and communities across the globe.Senior Contributing AuthorsRose M. Spielman, Formerly of Quinnipiac UniversityContributing AuthorsKathryn Dumper, Bainbridge State CollegeWilliam Jenkins, Mercer UniversityArlene Lacombe, Saint Joseph's UniversityMarilyn Lovett, Livingstone CollegeMarion Perlmutter, University of Michigan

By the end of this section, you will be able to:Describe how hunger and eating are regulatedDifferentiate between levels of overweight and obesity and the associated health consequencesExplain the health consequences resulting from anorexia and bulimia nervosa

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"A new clinical trial has shown promising results for those trying to shed excess pounds: researchers have zeroed in on a combination of herbal extracts that can significantly increase weight loss under the right circumstances. The news could mean better health for the more than 1 billion people who are overweight or obese worldwide. Traditional pharmaceutical and surgical options for weight management are expensive and often associated with adverse effects. The herbal formulation – composed of extracts from three common culinary spices used in Indian cooking – was developed as a high-quality natural alternative. The combination tackles excess body weight through a multi-layered approach, by both preventing fat cells from maturing and boosting existing fat break down. To determine the safety and efficacy of the extracts, researchers performed a randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.